OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Paresis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 2,209 reports · 52 co-occurring drugs

As of the last recalculation, Paresis appears in 2,209 FAERS reports alongside 52 co-occurring drug terms. The strongest observed disproportionality signal is SIPONIMOD (PRR 22.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Siponimod2122.422.4
Bupivacaine1818.318.3
Fingolimod Hcl12814.714.8
Captopril1312.812.8
Anti-Thymocyte Globulin (Rabbit)910.610.6
Candesartan3910.510.5
Alemtuzumab2110.310.3
Torsemide329.29.2
Lopinavir And Ritonavir139.19.1
Doxepin98.48.4
Melphalan208.48.4
Fondaparinux Sodium78.28.2
Bisacodyl Suppositories118.08.1
Ganciclovir Sodium98.08.0
Biscodyl118.08.0
Melphalan Hydrochloride207.67.6
Tranexamic Acid77.47.4
Ganciclovir87.47.4
Nebivolol127.17.1
Bendamustine Hydrochloride97.17.1
Valganciclovir Hydrochloride Powder,97.07.0
Botulinum Toxin Type A96.96.9
Efavirenz86.86.8
Rivastigmine136.56.5
Ofatumumab226.36.3
Bendamustine Hcl106.16.1
Erlotinib65.85.9
Ifosfamide135.75.7
Voriconazole Injection135.75.7
Busulfan95.45.4
Lamivudine Oral145.25.2
Cytarabine335.25.2
Fludarabine Phosphate215.15.1
Alteplase85.05.0
Levetiracetam In Sodium Chloride384.74.7
Levetiracetam Oral384.74.7
Levetiracetam Injection384.74.7
Erlotinib Hydrochloride64.54.5
Fesoterodine Fumarate54.44.4
Capecitabine394.14.1
Dabigatran Etexilate334.04.1
Dabigatran Etexilate Mesylate303.93.9
Vemurafenib53.93.9
Rifaximin83.63.6
Methoxy Polyethylene Glycol-Epoetin Beta43.43.4
Lumacaftor And Ivacaftor33.33.3
Pazopanib Hydrochloride93.13.1
Glatiramer Acetate193.03.0
Velpatasvir And Sofosbuvir42.92.9
Fam-Trastuzumab Deruxtecan-Nxki32.82.8
Dalfampridine202.62.6
Onabotulinumtoxina172.12.1

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.